Business Description
Elevai Labs Inc
NAICS : 541715
SIC : 2833
ISIN : US28622K1043
Description
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.36 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -2 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.75 | |||||
9-Day RSI | 25.04 | |||||
14-Day RSI | 28.06 | |||||
6-1 Month Momentum % | -44.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.57 | |||||
Quick Ratio | 1.8 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 313.41 | |||||
Days Sales Outstanding | 4.97 | |||||
Days Payable | 272.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -69.38 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.8 | |||||
Operating Margin % | -210.29 | |||||
Net Margin % | -211.25 | |||||
FCF Margin % | -276.94 | |||||
ROE % | -297.17 | |||||
ROA % | -144.95 | |||||
ROIC % | -334.45 | |||||
ROC (Joel Greenblatt) % | -696.92 | |||||
ROCE % | -260.87 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.09 | |||||
PB Ratio | 3.59 | |||||
Price-to-Tangible-Book | 5.02 | |||||
EV-to-EBIT | -1.91 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-Revenue | 4.01 | |||||
EV-to-FCF | -1.46 | |||||
Price-to-Net-Current-Asset-Value | 6.28 | |||||
Earnings Yield (Greenblatt) % | -52.36 | |||||
FCF Yield % | -63.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ELAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elevai Labs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.186 | ||
EPS (TTM) ($) | -0.267 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 28.06 | ||
14-Day ATR ($) | 0.031926 | ||
20-Day SMA ($) | 0.55669 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.4798 - 4.2442 | ||
Shares Outstanding (Mil) | 18.89 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Elevai Labs Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Elevai Labs Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Elevai Labs Inc Frequently Asked Questions
What is Elevai Labs Inc(ELAB)'s stock price today?
The current price of ELAB is $0.50. The 52 week high of ELAB is $4.24 and 52 week low is $0.48.
When is next earnings date of Elevai Labs Inc(ELAB)?
The next earnings date of Elevai Labs Inc(ELAB) is 2024-08-30 Est..
Does Elevai Labs Inc(ELAB) pay dividends? If so, how much?
Elevai Labs Inc(ELAB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |